Navigation Links
Scientists Unravel Link Between HRT And Breast Cancer Gene, BRCA1

It is a well established fact that any genetic alterations in either the BRCA1 or BRCA2 gene can predispose to breast cancer. The BRCA1 gene, has been known to play a significant role// in the utilization of estrogen in cells present in the breast. Researchers from Georgetown University Medical Center have now found that the BRCA1 gene also controls the activity of another important sex hormone, progesterone.

The results of the present study can be found in the latest issue of Molecular Endocrinology. This finding could eventually serve to explain the increased susceptibility of women with BRCA1 mutations to suffer form different forms of hormone dependent cancer, such as those of the cervix, endometrium and breast.

The researchers were interested in finding out how loss of BRCA1 activity could predispose to formation of hormone dependent tumors. Progesterone was taken up as the main target, as women who used hormone replacement therapy (HRT ) were found to have an increased cancer susceptibility than those on estrogen alone.

The utilization of progesterone is highly regulated. Furthermore, the activation occurs when there is a necessity for cell growth, such as during the menstrual cycle and during pregnancy. Specific receptor molecules, located inside the cell play a critical role in the binding and transport of progesterone. A gene expression is then manifested due to activation of the receptor.

In order to understand the role played by BRCA1 in signal transduction of the progesterone receptor, the researchers used breast cancer cell lines, sensitive to progesterone levels. These cell lines were genetically manipulated to either under express or over express the BRCA1 gene. Breast tissue, in which BRCA1 was partially deleted was also used for the study. The cell lines were treated with varying concentrations of estrogen, progesterone and estrogen-progesterone combination.

From the analysis of the results obtained, it was evident that BRCA1 gene interacted with the progesterone receptor (even in the absence of progesterone) to induce gene inactivation. This was in contrast to the growth stimulation of breast epithelial cells in mice (deficient in BRCA1) treated with the hormone combination.

The results of the present study have several valuable clinical implications. A majority of the breast tumors have deficient expression of the BRCA1 gene. Such patients could benefit by the administration of anti-estrogen therapy. The results of the present study further highlight that use of a specific anti-progesterone agent could maximize the clinical benefit.


'"/>




Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, ... steady since 2009, according to a Workers Compensation Research Institute (WCRI) study, a ... the North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and ...
(Date:5/23/2017)... ... May 23, 2017 , ... The National Council on ... to announce the organization’s Certified Strength Coach credential has earned accreditation from the ... program validates the competency of qualified candidates for jobs in the Strength and ...
(Date:5/23/2017)... ... 2017 , ... By all indications, and due to months of wet weather, ... diligence, asking homeowners to scout for any open water sources that can be emptied ... buzz of mosquitos is the buzz associated with potential infections stemming from their itchy ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... chat as a standard feature on its secure clinical communication platform. The platform ... to video depending on the type and urgency of a situation. , ...
(Date:5/23/2017)... CA (PRWEB) , ... May 23, 2017 , ... New ... gums and chronic bad breath, can now receive laser gum disease treatments from the ... Douglas Campbell and David Landau are raising awareness of the importance of receiving qualified ...
Breaking Medicine News(10 mins):
(Date:5/23/2017)... 2017  Leaf Healthcare, recognized for developing one ... pressure ulcer prevention, will unveil its comprehensive mobility ... Care Nurses, National Teaching Institute and Critical Care ... Leaf Patient Monitoring System is the first mobility ... The system seamlessly tracks patient movement throughout the ...
(Date:5/18/2017)... 18, 2017  Two Bayer U.S. Pharmaceutical leaders received ... its recent 28 th Woman of the ... showcases HBA,s longstanding mission of furthering the advancement and ... Cindy Powell-Steffen , senior director of brand ... and Libby Howe , a regional business manager ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
Breaking Medicine Technology: